Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors of pancreatic ductal adenocarcinoma
(2025) In Biochemistry and Biophysics Reports 44.- Abstract
Pancreatic cancer continues to be a major cause of cancer deaths worldwide. Characterizing the tumors of long-term survivors (≥5 years survival) would create opportunities in prognostic and therapeutic strategies. In this study, RNA sequencing data was used to identify differentially expressed genes (DEGs) in tumors of long-term survivors (LTS) vs short-term survivors (STS). Using LASSO-Cox regression, 4 prognostic DEGs, along with tumor stage, were utilized to develop a model for identifying high- and low-risk tumors. In Kaplan-Meier survival analysis, the high-risk group had significantly worse prognosis in both the training and validation cohorts. Using KEGG pathway gene signature sets, the high-risk group was found to have... (More)
Pancreatic cancer continues to be a major cause of cancer deaths worldwide. Characterizing the tumors of long-term survivors (≥5 years survival) would create opportunities in prognostic and therapeutic strategies. In this study, RNA sequencing data was used to identify differentially expressed genes (DEGs) in tumors of long-term survivors (LTS) vs short-term survivors (STS). Using LASSO-Cox regression, 4 prognostic DEGs, along with tumor stage, were utilized to develop a model for identifying high- and low-risk tumors. In Kaplan-Meier survival analysis, the high-risk group had significantly worse prognosis in both the training and validation cohorts. Using KEGG pathway gene signature sets, the high-risk group was found to have amplification of pathways, such as focal adhesion and ECM receptor interaction. The low-risk group, meanwhile, showed upregulation of specific metabolic pathways. Using ESTIMATE analysis, the high-risk group was found to have more stromal cell infiltration. Increased unpolarized macrophages and decreased inflammatory/anti-tumoral macrophages were also found in the high-risk group. Lastly, drug sensitivities were calculated and found to be generally higher in the high-risk group. This study reveals a model for predicting survival and drug sensitivity in pancreatic cancer. Genetic, molecular and tumor microenvironment characteristics of tumors from LTS and STS have been identified, highlighting opportunities for further research.
(Less)
- author
- Lin, Lizhi LU ; Norrsell, Ragnar LU ; Andersson, Roland LU ; Shen, Xian and Ansari, Daniel LU
- organization
- publishing date
- 2025-12
- type
- Contribution to journal
- publication status
- published
- subject
- keywords
- Drug sensitivity, Long-term survivors, Pancreatic cancer, Prognostic model, Transcriptomics, Tumor microenvironment
- in
- Biochemistry and Biophysics Reports
- volume
- 44
- article number
- 102280
- publisher
- Elsevier
- external identifiers
-
- pmid:41080752
- scopus:105016823613
- ISSN
- 2405-5808
- DOI
- 10.1016/j.bbrep.2025.102280
- language
- English
- LU publication?
- yes
- id
- 98616cd4-11d5-40ec-bd85-d72b84ffef3a
- date added to LUP
- 2025-11-21 15:55:40
- date last changed
- 2025-11-22 03:00:05
@article{98616cd4-11d5-40ec-bd85-d72b84ffef3a,
abstract = {{<p>Pancreatic cancer continues to be a major cause of cancer deaths worldwide. Characterizing the tumors of long-term survivors (≥5 years survival) would create opportunities in prognostic and therapeutic strategies. In this study, RNA sequencing data was used to identify differentially expressed genes (DEGs) in tumors of long-term survivors (LTS) vs short-term survivors (STS). Using LASSO-Cox regression, 4 prognostic DEGs, along with tumor stage, were utilized to develop a model for identifying high- and low-risk tumors. In Kaplan-Meier survival analysis, the high-risk group had significantly worse prognosis in both the training and validation cohorts. Using KEGG pathway gene signature sets, the high-risk group was found to have amplification of pathways, such as focal adhesion and ECM receptor interaction. The low-risk group, meanwhile, showed upregulation of specific metabolic pathways. Using ESTIMATE analysis, the high-risk group was found to have more stromal cell infiltration. Increased unpolarized macrophages and decreased inflammatory/anti-tumoral macrophages were also found in the high-risk group. Lastly, drug sensitivities were calculated and found to be generally higher in the high-risk group. This study reveals a model for predicting survival and drug sensitivity in pancreatic cancer. Genetic, molecular and tumor microenvironment characteristics of tumors from LTS and STS have been identified, highlighting opportunities for further research.</p>}},
author = {{Lin, Lizhi and Norrsell, Ragnar and Andersson, Roland and Shen, Xian and Ansari, Daniel}},
issn = {{2405-5808}},
keywords = {{Drug sensitivity; Long-term survivors; Pancreatic cancer; Prognostic model; Transcriptomics; Tumor microenvironment}},
language = {{eng}},
publisher = {{Elsevier}},
series = {{Biochemistry and Biophysics Reports}},
title = {{Prognostic model establishment and immune microenvironment analysis based on transcriptomic data of long-term survivors of pancreatic ductal adenocarcinoma}},
url = {{http://dx.doi.org/10.1016/j.bbrep.2025.102280}},
doi = {{10.1016/j.bbrep.2025.102280}},
volume = {{44}},
year = {{2025}},
}